Current or past participation in a study of an investigational agent or using an investigational device within four weeks of registration for protocol therapy
Current or planned participation in a study of an investigational agent or using an investigational device
Participation in a study of an investigational agent or device within  weeks of Day
Current or planned participation in a study of another investigational agent or using an investigational device.
Planned participation in another study of an investigational agent or investigational device or planned use of any other agent or therapeutic device intended for therapy of glioma
Current or planned participation in a study of an investigational agent or using an investigational device
Current or planned participation in a study of an investigational agent or using an investigational device
Current participation in or previous participation in a study of an investigational agent or using an investigational device within  weeks of the first dose of study treatment
Current participation in another clinical study of an investigational agent, vaccine, or device. Concomitant participation in observational studies is acceptable after sponsor approval.
Participation in any other investigational drug trial or exposure to other investigational agent, device or procedure within  days
Current or planned participation in a study of an investigational agent or using an investigational device
Participation in an investigational research study using an investigational agent within  days of screening
Participation in concurrent study of an investigational agent or device.
Current enrollment in an investigational drug or device study, or participation in such a study within  days of first administration of the hormonal agent
Planned participation in another study of an investigational agent or investigational device or use of a therapeutic device intended for therapy of glioma